Page last updated: 2024-08-23

acifran and Dyslipidemia

acifran has been researched along with Dyslipidemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boatman, PD; Richman, JG; Semple, G1
Chen, R; Connolly, DT; Dang, TH; Pride, CC; Richman, JG; Sage, CR; Semple, G; Skinner, PJ; Tamura, SY; Webb, PJ1

Reviews

1 review(s) available for acifran and Dyslipidemia

ArticleYear
Nicotinic acid receptor agonists.
    Journal of medicinal chemistry, 2008, Dec-25, Volume: 51, Issue:24

    Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Dyslipidemias; Humans; Kinetics; Ligands; Mice; Models, Chemical; Nicotinic Agonists; ortho-Aminobenzoates; Receptors, G-Protein-Coupled; Receptors, Nicotinic

2008

Other Studies

1 other study(ies) available for acifran and Dyslipidemia

ArticleYear
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.
    Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15

    Topics: Animals; Atherosclerosis; Carboxylic Acids; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Cricetulus; Drug Design; Dyslipidemias; Humans; Ligands; Lipoproteins, HDL; Lipoproteins, LDL; Models, Chemical; Niacin; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic

2009